Multidisciplinary Management of Resectable Early-Stage Non-Small Cell Lung Cancer

J Adv Pract Oncol. 2022 Apr;13(3):306-310. doi: 10.6004/jadpro.2022.13.3.25. Epub 2022 May 23.

Abstract

During JADPRO Live Virtual 2021, three advanced practitioners-in surgery, radiation oncology, and medical oncology-discussed their collaboration in the management of resectable early-stage non-small cell lung cancer. The presenters discussed the role of screening and early surgical resection, cancer surveillance after resection, adjuvant and neoadjuvant therapies, as well as novel therapies and their associated toxicities.